Fecal transplants from responding patients into mice has shown to improve tumor control, augment T cell responses, and increase the efficacy of anti-PD-L1 therapy (124) or PD-1 therapy (125), showing promise as a potential sensitizing strategy. This evidence concerns the gene CD274 and neoplasm.